• Disease areas
  • Products
  • Sustainable business
  • Partnering & innovation
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Investors
  • News & media
  • Contact us

Latest news

{{'Wed, 29 Nov 2023 18:29:00 -0500' | dateFormatUsFilter}}

Novo Nordisk takes additional legal actions to help protect US patients from potentially unsafe and ineffective compounded drugs claiming to contain semaglutide that are not FDA approved

Read more

{{'Sat, 11 Nov 2023 08:30:00 -0500' | dateFormatUsFilter}}

Wegovy® (semaglutide) injection 2.4 mg cardiovascular outcomes data presented at the American Heart Association Scientific Sessions and simultaneously published in the New England Journal of Medicine

Read more

{{'Tue, 07 Nov 2023 08:30:00 -0500' | dateFormatUsFilter}}

Novo Nordisk to present new cardiometabolic disease data, including results from SELECT, at the annual American Heart Association Scientific Sessions

Read more

News archive

Career opportunities

Dear colleague

You are in the wrong place, click here to go directly to our internal career site to view all our current job opening.

Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.

NOVO NORDISK USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

CVR-no. 24256790

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

Contact us Copyright Report a side effect or product complaint

Follow us

Facebook X (Twitter) Instagram

Other offices

Select country
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Cookie Policy
Privacy Request

change